Last reviewed · How we verify

NCT05810129: crossed1

Crossed Education in Relation to Muscle Mass in Patients Operated of Clavicular Fracture

Recruiting now NA Last updated 22 January 2025
What this trial tests

NA trial testing concentric-eccentric strength training in Clavicle Fracture in 39 participants. Currently enrolling.

Timeline
2 May 2023
Primary endpoint
31 July 2025
30 October 2025

Quick facts

Lead sponsorUniversidad de La Frontera
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment39
Start date2 May 2023
Primary completion31 July 2025
Estimated completion30 October 2025
Sites1 location across Chile

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de La Frontera — full company profile →

Who can join

Adults 18 to 40, male only, with Clavicle Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The immobilization process after an operation or injury in the upper extremity causes a loss of muscle mass and strength of 0.2% and 1.3% per day, respectively. Currently, the use of cross-education, which is unilateral training in the uninjured limb, during the immobilization period, is expanding, demonstrating a magnitude of strength gain in the immobilized limb from 8% to 77% of the mean of strength of the trained limb. Despite the evidenced benefits of cross-education in unilateral injuries such as distal radius fracture, anterior cruciate ligament injury, and knee replacement, very little is known about this effect in shoulder immobilization after clavicle fracture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Clavicle Fracture

Currently open trials in the same condition.

Other Universidad de La Frontera trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05810129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing